ArticleAmerican journal of cancer research2024

Recurrence risk of erythropoiesis-stimulating agents on early-stage urothelial carcinoma in patients with end stage renal disease.

Hui-Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.